Outcomes15

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 15 of 15

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Time to Improvement in Coronavirus Disease 2019 (COVID-19) Clinical Status	Up to Day 29	All randomized participants	Days	MEDIAN
PRIMARY	Number of Participants Who Experience an Adverse Event (AE)	Up to 30 days	All randomized participants who received at least one dose of treatment.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Percentage of Participants Who Died or Had Respiratory Failure (RF)	Up to Day 29	All randomized participants	Percentage of Participants	NUMBER
SECONDARY	Time to Disease Progression in Clinical Status of COVID-19	Up to Day 29	All randomized participants	Days	MEDIAN
SECONDARY	Number of Participants Who Died Due to Any Cause	Up to Day 29	All randomized participants	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Rate of Clinical Relapse	Up to Day 29	All randomized participants	Percentage of Participants	NUMBER
SECONDARY	Conversion Rate of COVID-19 Clinical Status	Up to Day 15	All randomized participants	Percentage of participants	NUMBER
SECONDARY	Time to Hospital Discharge	Up to Day 29	All randomized participants	Days	MEDIAN
SECONDARY	Duration of MV	Up to Day 29	All randomized participants who received MV	Days	MEAN
SECONDARY	Duration of Pressors	Up to Day 29	All randomized participants who received pressors	Days	MEAN
SECONDARY	Duration of ECMO	Up to Day 29	All randomized participants who received ECMO	Days	MEAN
SECONDARY	Duration of High Flow Oxygen Therapy	Up to Day 29	All randomized participants who received high flow oxygen therapy	Days	MEAN
SECONDARY	Length of Hospital Stay	Up to 90 days	All randomized participants	Days	MEAN
SECONDARY	Change From Baseline in Absolute Lymphocyte Count	Baseline and up to Day 15	All randomized participants with lymphocyte data available	10^9 Cells/Liter	MEAN
SECONDARY	Change From Baseline in D-Dimer Concentration	Baseline and up to Day 15	All randomized participants with D-dimer concentration data available	nmol/Liter	MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04317040/outcomes

API reference For AI assistants